Review Article

Role of Matrix Metalloproteinase-2 in the Development of Atherosclerosis among Patients with Coronary Artery Disease

Table 2

PRISMA 2020 for abstract checklist [31].

Section and topicItem #Checklist itemLocation where Item is reported

Title1Identify the report as a systematic reviewAbstract, line 5.
Background
Objectives2Provide an explicit statement of the main objective (s) or question (s) the review addressesAbstract, line 5
Methods
Eligibility criteria3Specify the inclusion and exclusion criteria for the reviewNot stated in abstract
Information sources4Specify the information sources (e.g., databases and registers) used to identify studies and the date when each was last searchedAbstract, line 6 and 7
Risk of bias5Specify the methods used to assess risk of bias in the included studiesAbstract, line 7
Synthesis of results6Specify the methods used to present and synthesize resultsAbstract, line 6–8
Results
Included studies7Give the total number of included studies and participants and summarize relevant characteristics of studiesAbstract, line 8
Synthesis of results8Present results for main outcomes, preferably indicating the number of included studies and participants for each. If meta-analysis was done, reports the summary estimate and confidence/credible interval. If comparing groups, indicate the direction of the effects (i.e., which group is favored)Abstract, line 8–12
Discussion
Limitation of evidence9Provide a brief summary of the limitations of the evidence included in the review (e.g., study risk of bias, inconsistency, and imprecision).Not stated in abstracts
Interpretation10Provide a general interpretation of the results and important implicationsAbstract, line 13 and 14
Other
Funding11Specify the primary source of funding for the reviewNot stated in abstracts
Registration12Provide the register name and registration numberNot stated in abstracts